Following the recent acquisition of the world-leading Materia catalyst business by Umicore, we’ve been granted an exclusive interview with Robert Grubbs, chemistry Nobel laureate and co-founder of Materia.
Making drugs is neither easy nor cheap – but catalysts, flow chemistry and a knowledge of intermolecular interactions can help
More big pharmaceutical companies are collaborating with universities
Less toxic than quantum dots, can conjugated polymer nanoparticles revolutionise bioimaging?
How spray drying can help with solubility and bioavailability challenges in drug development
How do healthcare products get from academic or start-up labs to the clinic? With a little help from places like the Centre for Process Innovation
In a world that is racing ahead with new technologies, has the drug development process distanced itself from the patients it ultimately provides for?
Automated tools can take the drudgery out of routine lab work, Anthony King reports
With rising concerns over gadolinium, Anthony King looks at the alternatives under development
Katrina Megget discovers that where we live, work and visit can be linked to our health